Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 23-Jan-24 8:37 PM View:  | Mirati Therapeutics, Inc. (MRTX) | 23-Jan-24 | Disposition | 117,028 | -- | -- | (100%) 117.03K to 0 | |
| 18-Jan-24 4:45 PM View: | Mirati Therapeutics, Inc. (MRTX) | 16-Jan-24 | Sale | 1,597 | $59.02 | $94,254.90 | (1%) 118.63K to 117.03K | |
| 09-Jan-24 5:54 PM View: | Mirati Therapeutics, Inc. (MRTX) | 08-Jan-24 | Sale | 2,090 | $58.92 | $123,143.00 | (2%) 120.72K to 118.63K | |
| 03-Jan-24 6:13 PM View: | Mirati Therapeutics, Inc. (MRTX) | 29-Dec-23 | Grant | 17,021 | $58.75 | $999,984.00 | 16% 103.69K to 120.72K | |
| 14-Dec-23 5:05 PM View: | Mirati Therapeutics, Inc. (MRTX) | 13-Dec-23 | Sale | 2,220 | $56.67 | $125,807.00 | (2%) 105.91K to 103.69K | |
| 10-Aug-23 4:23 PM View: | Mirati Therapeutics, Inc. (MRTX) | 09-Aug-23 | Grant | 22,297 | $37.00 | $824,989.00 | 27% 83.62K to 105.91K | |
| 24-Jan-23 4:00 PM View: | Mirati Therapeutics, Inc. (MRTX) | 20-Jan-23 | Grant | 36,394 | -- | -- | 77% 47.22K to 83.62K | |
| 19-Jan-23 9:45 AM View: | Mirati Therapeutics, Inc. (MRTX) | 17-Jan-23 | Sale | 1,566 | $42.38 | $66,366.00 | (3%) 48.79K to 47.22K | |
| 10-Jan-23 5:00 PM View: | Mirati Therapeutics, Inc. (MRTX) | 09-Jan-23 | Sale | 2,088 | $45.37 | $94,732.60 | (4%) 50.88K to 48.79K | |
| 21-Dec-22 9:20 PM View: | Mirati Therapeutics, Inc. (MRTX) | 21-Dec-22 | Sale | 3,248 | $40.41 | $131,266.00 | (6%) 54.13K to 50.88K | |
| 21-Dec-22 9:20 PM View: | Mirati Therapeutics, Inc. (MRTX) | 19-Dec-22 | Grant | 19,149 | -- | -- | 55% 34.98K to 54.13K | |
| 18-Jan-22 8:32 PM View: | Mirati Therapeutics, Inc. (MRTX) | 18-Jan-22 | Sale | 627 | $120.48 | $75,542.70 | (2%) 35.6K to 34.98K | |
| 18-Jan-22 8:32 PM View: | Mirati Therapeutics, Inc. (MRTX) | 14-Jan-22 | Grant | 10,755 | -- | -- | 43% 24.85K to 35.6K | |
| 07-Jan-22 8:27 PM View: | Mirati Therapeutics, Inc. (MRTX) | 07-Jan-22 | Market Sale | 1,964 | $135.94 | $266,984.00 | (7%) 26.81K to 24.85K | (< 1%) |
| 22-Mar-21 4:42 PM View: | Mirati Therapeutics, Inc. (MRTX) | 19-Mar-21 | Option Exercise | 2,369 | $114.33 | $270,848.00 | 9% 26.81K to 29.18K | |
| 22-Mar-21 4:42 PM View: | Mirati Therapeutics, Inc. (MRTX) | 19-Mar-21 | Market Option Sale (Planned) | 2,369 | $176.44 | $417,978.00 | (8%) 29.18K to 26.81K | |
| 20-Jan-21 6:18 PM View: | Mirati Therapeutics, Inc. (MRTX) | 15-Jan-21 | Grant | 7,023 | -- | -- | 35% 19.79K to 26.81K | |
| 08-Jan-21 7:46 PM View: | Mirati Therapeutics, Inc. (MRTX) | 07-Jan-21 | Market Sale | 2,078 | $216.33 | $449,525.00 | (10%) 21.87K to 19.79K | (1%) |
| 08-Jan-20 9:06 PM View: | Mirati Therapeutics, Inc. (MRTX) | 06-Jan-20 | Grant | 21,867 | -- | -- | 100% 0 to 21.87K | |
| 01-Oct-19 7:10 PM View: | Halozyme Therapeutics, Inc. (HALO) | 01-Oct-19 | Payment of Exercise | 6,990 | $15.46 | $108,065.00 | (35%) 20.22K to 13.23K | |
| 01-Oct-19 7:10 PM View: | Halozyme Therapeutics, Inc. (HALO) | 01-Oct-19 | Option Exercise | 20,216 | -- | -- | 100% 0 to 20.22K |